Fig. 5
From: IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
Aberrant GPRC5A and IMUP gain of expression in PAAD comparing to normal pancreatic tissues. A The hydrophilcity / hydrophobicity analysis of GPRC5A protein by ProtScale. B The prediction model of the cellular location of GPRC5A protein. C The hydrophilcity / hydrophobicity analysis of IMUP protein by ProtScale. D The prediction model of the cellular location of IMUP protein. E Expression of GPRC5A in different types of human cancers. F Aberrant gain of expression of GPRC5A in PAAD comparing to normal pancreatic tissues. G The correlation analysis of GPRC5A and IMUP in PAAD. H Expression of IMUP in different types of human cancers. I Aberrant gain of expression of IMUP in PAAD comparing to normal pancreatic tissues. J Overall survival analysis of four group of PAAD patients with GPRC5A-/IMUP-, GPRC5A-/IMUP + , GPRC5A + /IMUP- and GPRC5A + /IMUP + expression respectively. K One of the tissue arrays made by local hospital PAAD samples and the HE staining of the array. The relative expression of GPRC5A in L PAAD cancer and M normal pancreatic tissues revealed by IHC experiment of the tissue array. The relative expression of IMUP in N PAAD cancer and O normal pancreatic tissues revealed by IHC experiment of the tissue array